2019 annual financial data
Immix Biopharma 2019 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -842,499 USD and net income was -972,811 USD.
Operating cash flow was -790,032 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -842,499 USD
- Net income
- -972,811 USD
- Operating cash flow
- -790,032 USD